Loading...
Clinical implications of mismatch repair deficiency in prostate cancer
Immune checkpoint blockade holds great promise in the treatment of solid tumors but has not yet been approved for use in advanced prostate cancer. This is largely due to the relatively modest response in clinical trials in unselected patients and the lack of available biomarkers to predict clinical...
Na minha lista:
| Udgivet i: | Future Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Future Medicine Ltd
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6714067/ https://ncbi.nlm.nih.gov/pubmed/31237441 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2019-0068 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|